Last reviewed · How we verify

Lidocaine-Prilocaine Cream 2.5-2.5%

Centre Hospitalier le Mans · FDA-approved active Small molecule

Lidocaine and prilocaine are local anesthetics that block sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Lidocaine and prilocaine are local anesthetics that block sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. Used for Topical anesthesia of intact skin prior to minor procedures (venipuncture, IV insertion, laser treatment), Topical anesthesia of genital mucous membranes.

At a glance

Generic nameLidocaine-Prilocaine Cream 2.5-2.5%
SponsorCentre Hospitalier le Mans
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

Both lidocaine and prilocaine work by inhibiting sodium influx through voltage-gated sodium channels in nerve fibers, which prevents depolarization and action potential generation. This combination cream is applied topically to provide rapid local anesthesia and analgesia. The eutectic mixture (EMLA) formulation allows both agents to penetrate the skin effectively as an oil-in-water emulsion.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: